Concepedia

Trevor Lissoos

TL

Statistics

Publications

22

Citations

1.5K

H-Index

18

Active since

1998

Affiliations

Takeda (United States)(Current)

University of Chicago

Icahn School of Medicine at Mount Sinai

Deerfield (United States)

Eli Lilly (United States)

Trevor Lissoos is an author at Takeda (United States) specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and medicine.

Publications per year

1998–2023

22

Publications

22

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Geert D’Haens, Marla C. Dubinsky, Taku Kobayashi et al. · New England Journal of Medicine · 2023 · 317 citations · Full text

, , +17

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

Jules L. Dienstag, Eugene R. Schiff, Mack C. Mitchell et al. · Hepatology · 1999 · 196 citations · Full text

, , +17

CLINICAL COURSE AND MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AFTER LIVER TRANSPLANTATION

Alex S. Befeler, Trevor Lissoos, Thomas D. Schiano et al. · Transplantation · 1998 · 128 citations

, , +16

Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2

Brian G. Feagan, David A. Schwartz, Silvio Danese et al. · Journal of Crohn s and Colitis · 2018 · 117 citations · Full text

, , +14

Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases

Brian G. Feagan, Karen Lasch, Trevor Lissoos et al. · Clinical Gastroenterology and Hepatology · 2018 · 109 citations · Full text

, , +16

1–5 of 22